Keurig Dr Pepper Inc. Common Stock vs Zimmer Biomet Holdings Inc — how do they compare? Keurig Dr Pepper Inc. Common Stock trades at $31.76 (market cap $42.54B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Keurig Dr Pepper Inc. Common Stock is far larger — about 2.5× Zimmer Biomet Holdings Inc's market cap, and Keurig Dr Pepper Inc. Common Stock pays the higher dividend (2.94%). Which is the better fit depends on your goals — on Pluang, investors hold Keurig Dr Pepper Inc. Common Stock for 1 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| KDP | ZBH | |
|---|---|---|
Market Cap | $42.54B | $16.95B |
Volume | 14,530,234 | 2,505,240 |
Sector | Consumer Staples | Health |
52-Week High | $33.50 | $103.98 |
52-Week Low | $25.31 | $79.58 |
Typical Hold Time | 1 Days | 89 Days |
Enterprise Value | $71.00B | $24.02B |
Dividend Yield | 2.94% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and maintains a solid gross profit margin of 69.87%. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated. Analyst consensus is a 'Buy' with a $103.11 price target, indicating potential upside from current levels.
The outlook for ZBH is cautiously optimistic, supported by earnings momentum and a diversified medical technology portfolio. Key risks include rising debt levels, with debt-to-asset ratio increasing to 32.57% in 2025, and competitive pressures in the healthcare sector. Institutional ownership trends show continued interest, but investors should monitor margin sustainability and capital expenditure efficiency.
Trailing returns across standard periods
Latest headlines on both assets
Keurig Dr Pepper produces and distributes coffee, soft drinks, juices, and other beverages. It also operates the Keurig single-serve coffee system.
Read more on KDP →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →